Armando Luis Munoz, 14155

Armando Munoz practices at Centro San Cristobal Juana Diaz - Juana Diaz in Juana Diaz, Puerto Rico.

Armando Munoz's NPI, 1336353184, was assigned on May 10, 2007. Armando Munoz holds Puerto Rico license 14155.

Armando Munoz's primary practice is Centro San Cristobal Juana Diaz - Juana Diaz, at 6 Calle La Cruz, Juana Diaz, PR 00795-2430. The practice phone is (787) 837-2265.

Armando Munoz's primary practice is Centro San Cristobal Juana Diaz - Juana Diaz in Juana Diaz, Puerto Rico. The medical group on file is Centro San Cristóbal. Dmand AI also links Armando Munoz to 1 more home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Armando Munoz practices, 3 sites in all. Vendor and product names are available with a free account.

General practice is Armando Munoz's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Armando Munoz is licensed in Puerto Rico.

CMS data shows 34 Medicare services from Armando Munoz across 1 procedure code in 2024, for 42 Medicare patients. Medicare paid $1,308 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Armando Munoz in 2024. The largest group is 65 to 74, with 16 patients. 69% of them have high blood pressure, and 60% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Armando Munoz's median patient age at 71, with 75% women.

In 2024, Armando Munoz wrote 24,858 Medicare Part D claims for 1,422 patients. 89% of them were for generic drugs. CMS names the drug for 24,285 of them, across 173 drugs with 11 or more claims each, at $561,551 in total drug cost. In 2023, CMS named 22,821 claims across 158 drugs.

Armando Munoz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 11 general payments to Armando Munoz from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $145.